Evaluation of adjuvant therapy for t1-2n1mim0 breast cancer without further axillary lymph node dissection

HIGHLIGHTS

  • who: Baiyu Li and collaborators from the (UNIVERSITY) have published the article: Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection, in the Journal: (JOURNAL)

SUMMARY

    @@

ACRONYMS

LAY DEFINITIONS

  • adjuvant: An adjuvant is a pharmacological or immunological agent that improves the immune response of a vaccine. Adjuvants may be added to a vaccine to boost the immune response to produce more antibodies and longer-lasting immunity, thus minimizing the dose of antigen needed
  • cancer: Cancer is a group of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?